Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1994 May;37(5):427–431. doi: 10.1111/j.1365-2125.1994.tb05709.x

Between-subject and within-subject variations in the pharmacokinetics of ethanol.

A W Jones 1, K A Jönsson 1
PMCID: PMC1364897  PMID: 8054248

Abstract

1. Twelve healthy men drank 0.80 g ethanol kg-1 body weight on four occasions spread over several weeks. Ethanol was given as 96% v/v solvent which was diluted with orange juice to make a cocktail (20-25% v/v). This drink was ingested in exactly 30 min at 08.00 h after an overnight (10 h) fast. 2. Samples of venous blood were obtained at exactly timed intervals of 0, 10, 20, 30, 45, 60, 90, 120, 150, 180, 240, 300, and 360 min after the start of drinking. The concentrations of ethanol in whole blood were determined by headspace gas chromatography. 3. Summary measures were used to evaluate the concentration-time profiles of ethanol for each subject. The between-subject and within-subject components of variation for the pharmacokinetics of ethanol were derived by one-way analysis of variance (ANOVA). 4. The variation between different subjects dominated the total variance for all of the pharmacokinetic parameters studied except the rate of disappearance of ethanol from blood (ko). For this latter parameter, 42% and 58% of the total variation arose from variations between- and within-subjects respectively. These results might be important to consider when experiments on the clinical pharmacokinetics of ethanol are being planned.

Full text

PDF
427

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Evans S. J. Uses and abuses of analysis of variance. Br J Clin Pharmacol. 1983 Jun;15(6):629–648. doi: 10.1111/j.1365-2125.1983.tb01544.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hills M., Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979 Jul;8(1):7–20. doi: 10.1111/j.1365-2125.1979.tb05903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Jackson P. R., Tucker G. T., Woods H. F. Backtracking booze with Bayes--the retrospective interpretation of blood alcohol data. Br J Clin Pharmacol. 1991 Jan;31(1):55–63. doi: 10.1111/j.1365-2125.1991.tb03857.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Jones A. W. Disappearance rate of ethanol from the blood of human subjects: implications in forensic toxicology. J Forensic Sci. 1993 Jan;38(1):104–118. [PubMed] [Google Scholar]
  5. Jones A. W. Interindividual variations in the disposition and metabolism of ethanol in healthy men. Alcohol. 1984 Sep-Oct;1(5):385–391. doi: 10.1016/0741-8329(84)90008-9. [DOI] [PubMed] [Google Scholar]
  6. Jones A. W., Schuberth J. Computer-aided headspace gas chromatography applied to blood-alcohol analysis: importance of online process control. J Forensic Sci. 1989 Sep;34(5):1116–1127. [PubMed] [Google Scholar]
  7. Jönsson K. A., Jones A. W., Boström H., Andersson T. Lack of effect of omeprazole, cimetidine, and ranitidine on the pharmacokinetics of ethanol in fasting male volunteers. Eur J Clin Pharmacol. 1992;42(2):209–212. doi: 10.1007/BF00278486. [DOI] [PubMed] [Google Scholar]
  8. Kopun M., Propping P. The kinetics of ethanol absorption and elimination in twins and supplementary repetitive experiments in singleton subjects. Eur J Clin Pharmacol. 1977;11(5):337–344. doi: 10.1007/BF00566530. [DOI] [PubMed] [Google Scholar]
  9. Martin N. G., Perl J., Oakeshott J. G., Gibson J. B., Starmer G. A., Wilks A. V. A twin study of ethanol metabolism. Behav Genet. 1985 Mar;15(2):93–109. doi: 10.1007/BF01065891. [DOI] [PubMed] [Google Scholar]
  10. Passananti G. T., Wolff C. A., Vesell E. S. Reproducibility of individual rates of ethanol metabolism in fasting subjects. Clin Pharmacol Ther. 1990 Mar;47(3):389–396. doi: 10.1038/clpt.1990.44. [DOI] [PubMed] [Google Scholar]
  11. Petring O. U., Flachs H. Inter- and intrasubject variability of gastric emptying in healthy volunteers measured by scintigraphy and paracetamol absorption. Br J Clin Pharmacol. 1990 Jun;29(6):703–708. doi: 10.1111/j.1365-2125.1990.tb03691.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rodbard D. Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem. 1974 Oct;20(10):1255–1270. [PubMed] [Google Scholar]
  13. Vesell E. S., Page J. G., Passananti G. T. Genetic and environmental factors affecting ethanol metabolism in man. Clin Pharmacol Ther. 1971 Mar-Apr;12(2):192–201. doi: 10.1002/cpt1971122part1192. [DOI] [PubMed] [Google Scholar]
  14. Wagner J. G. Intrasubject variation in elimination half-lives of drugs which are appreciably metabolized. J Pharmacokinet Biopharm. 1973 Apr;1(2):165–173. doi: 10.1007/BF01059628. [DOI] [PubMed] [Google Scholar]
  15. Woods J. R., Williams J. G., Tavel M. The two-period crossover design in medical research. Ann Intern Med. 1989 Apr 1;110(7):560–566. doi: 10.7326/0003-4819-110-7-560. [DOI] [PubMed] [Google Scholar]
  16. al-Lanqawi Y., Moreland T. A., McEwen J., Halliday F., Durnin C. J., Stevenson I. H. Ethanol kinetics: extent of error in back extrapolation procedures. Br J Clin Pharmacol. 1992 Oct;34(4):316–321. doi: 10.1111/j.1365-2125.1992.tb05636.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES